PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 31, 2025Academic Science Journal0 citationsOpen Access

Some Biochemical Markers in Type 1 Diabetes Patients

View Full Paper
DADhifaf Abdul adheemEHEkhlas Abdallah Hassan

Key Points

  • Type 1 diabetes patients exhibited significant increases in glycated haemoglobin and urea levels compared to healthy controls.
  • Patients showed elevated cholesterol levels, including total cholesterol and low-density lipoprotein cholesterol, alongside fasting blood sugar.
  • Biochemical markers such as triglycerides were significantly lower in type 1 diabetes patients than in controls, suggesting altered lipid metabolism.
  • The findings highlight metabolic vulnerabilities in type 1 diabetes, emphasizing the need for further research into associated complications.

Abstract

Type 1 diabetes mellitus (T1DM) is characterized by hyperglycaemia in combination with biochemical changes in glucose, lipid profile and glycated haemoglobin (HbA1c). This study aims to assess glucose, lipid profile, glycated haemoglobin (HbA1c), UREA and Creatinine in type 1 diabetic subjects. Type 1 patients were selected from the subjects attending National Center of Diabetes (AL- Mustansiria University) the number of patients are 90 the number of male are 47 the number of female are 43. Fasting blood sugar (FBS), lipid profile were determined by enzymatic methods, glycated haemoglobin (HbA1c) was measured by (HPLC), UREA and Creatinine (by kinetic method) in patients were compared with healthy controls there number are 30. type 1 diabetic patients showed statistically significant increase in the levels of HbA1c, urea, creatinine , FBS, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), whereas statistically significant decreased level was found in triglycerides (TGs) and very low- density lipoprotein(VLDL). In addition, HDL/LDL ratio were significantly higher than the control subject was. In conclusion: There are associated biological vulnerabilities to type 1 diabetes compare to the control subjects. Further research is warranted to quantify the magnitude of complications and confirm their observation in clinical populations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

adheem et al. (2025) studied this question.

synapsesocial.com/papers/68af61fdad7bf08b1eae2886https://doi.org/10.24237/asj.03.03.860b
Ask AI
Helpful
Bookmark
Share
View Full Paper